Arimura-Omori Masako, Kiyohara Chikako, Yanagihara Toyoshi, Yamamoto Yuzo, Ogata-Suetsugu Saiko, Harada Eiji, Hamada Naoki, Tsuda Toru, Takata Shohei, Shimabukuro Ikuko, Nagata Nobuhiko, Yatera Kazuhiro, Torii Ryo, Okamoto Masaki, Fujita Masaki, Nakanishi Yoichi
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University,Fukuoka,Japan.
Asian Pac J Cancer Prev. 2020 Mar 1;21(3):667-673. doi: 10.31557/APJCP.2020.21.3.667.
Lung cancer coexisting with idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) can lead to poor prognosis. Telomere-related polymorphisms may be implicated in the pathogenesis of these three lung diseases. As to elucidate the mechanism of lung cancer via IPF or COPD may enable early detection and early treatment of the disease, we firstly examined the association between telomere-related polymorphisms and the risk of IPF and COPD in a case-control study.
A total of 572 patients with IPF (n = 155) or COPD (n = 417), who were derived from our on-going cohort study, and controls (n = 379), who were derived from our previous case-control study, were included in this study. Telomerase reverse transcriptase (TERT) rs2736100, telomere RNA component (TERC) rs1881984, and oligonucleotide/oligosaccharide-binding fold containing1 (OBFC1) rs11191865 were genotyped with real-time PCR using TaqMan fluorescent probes. Unconditional logistic regression was used to assess the adjusted odds ratios and 95% confidence intervals.
TERT rs2736100 was significantly associated with the risk of IPF; increases in the number of this risk allele increased the risk of IPF (Ptrend = 0.008). Similarly, TERT rs2736100 was associated with the risk of COPD. In regard to the combined action of the three loci, increasing numbers of "at-risk" genotypes increased the risk of IPF in a dose-dependent manner (P trend=0.003).
TERT rs2736100 was associated with the risks of both IPF and COPD in a Japanese population. A combination of the "at-risk" genotypes might be important to identify the population at risk for IPF more clearly.
肺癌合并特发性肺纤维化(IPF)或慢性阻塞性肺疾病(COPD)可导致预后不良。端粒相关多态性可能与这三种肺部疾病的发病机制有关。为了阐明通过IPF或COPD引发肺癌的机制,从而实现疾病的早期检测和早期治疗,我们首先在一项病例对照研究中检测了端粒相关多态性与IPF和COPD风险之间的关联。
本研究纳入了572例IPF患者(n = 155)或COPD患者(n = 417),这些患者来自我们正在进行的队列研究,以及379例对照,这些对照来自我们之前的病例对照研究。使用TaqMan荧光探针通过实时PCR对端粒酶逆转录酶(TERT)rs2736100、端粒RNA成分(TERC)rs1881984和含寡核苷酸/寡糖结合折叠1(OBFC1)rs11191865进行基因分型。采用无条件逻辑回归评估调整后的比值比和95%置信区间。
TERT rs2736100与IPF风险显著相关;该风险等位基因数量增加会增加IPF风险(Ptrend = 0.008)。同样,TERT rs2736100与COPD风险相关。关于这三个基因座的联合作用,“风险”基因型数量增加会以剂量依赖方式增加IPF风险(P趋势 = 0.003)。
在日本人群中,TERT rs2736100与IPF和COPD风险均相关。“风险”基因型的组合可能对更清楚地识别IPF高危人群很重要。